Focus on solifenacin

Abstract

Overactive bladder syndrome (OAB) is a chronic medical condition that can have a major effect on quality of life. OAB causes a frequent and sudden urge to urinate that may be difficult to control and can also lead to urinary incontinence.¹ First-line treatment starts with behavioural therapies such as bladder training, pelvic floor muscle exercises, and fluid management. After lifestyle interventions, anticholinergic drugs are the next step in treating OAB. Antimuscarinics are the drug class of choice for OAB symptoms and have proven efficacy.^1-3